These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 36366731)

  • 1. Metabolism-related lncRNAs signature to predict the prognosis of colon adenocarcinoma.
    Sun Y; Liu B; Xiao B; Jiang X; Xiang JJ; Xie J; Hu XM
    Cancer Med; 2023 Mar; 12(5):5994-6008. PubMed ID: 36366731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction.
    Li X; Lei J; Shi Y; Peng Z; Gong M; Shu X
    Curr Med Chem; 2024; 31(17):2449-2466. PubMed ID: 37961859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
    Huang W; Liu Z; Li Y; Liu L; Mai G
    J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.
    Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J
    Front Immunol; 2022; 13():881359. PubMed ID: 35911752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
    Xu M; Mu J; Wang J; Zhou Q; Wang J
    Front Oncol; 2022; 12():961213. PubMed ID: 35965536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
    Front Oncol; 2022; 12():876660. PubMed ID: 35747790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma.
    Fu X; Duanmu J; Li T; Jiang Q
    PeerJ; 2020; 8():e8877. PubMed ID: 32309045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma.
    Zeng JH; Liang L; He RQ; Tang RX; Cai XY; Chen JQ; Luo DZ; Chen G
    Oncotarget; 2017 Mar; 8(10):16811-16828. PubMed ID: 28187432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma.
    Wang Y; Huang X; Chen S; Jiang H; Rao H; Lu L; Wen F; Pei J
    Curr Oncol; 2022 Sep; 29(9):6573-6593. PubMed ID: 36135086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
    Jin L; Li C; Liu T; Wang L
    Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic risk assessment model and drug sensitivity analysis of colon adenocarcinoma (COAD) based on immune-related lncRNA pairs.
    Hao Z; Liang P; He C; Sha S; Yang Z; Liu Y; Shi J; Zhu Z; Chang Q
    BMC Bioinformatics; 2022 Oct; 23(1):435. PubMed ID: 36258178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and validation of a prognostic model based on HRR-related lncRNAs in colon adenocarcinoma.
    Tang X; Lin Y; He J; Luo X; Liang J; Zhu X; Li T
    World J Surg Oncol; 2022 Mar; 20(1):74. PubMed ID: 35264195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and Validation of a Reliable Disulfidptosis-Related LncRNAs Signature of the Subtype, Prognostic, and Immune Landscape in Colon Cancer.
    Dong X; Liao P; Liu X; Yang Z; Wang Y; Zhong W; Wang B
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose metabolism-based signature predicts prognosis and immunotherapy strategies for colon adenocarcinoma.
    Bai Z; Yan C; Nie Y; Zeng Q; Xu L; Wang S; Chang D
    J Gene Med; 2024 Jan; 26(1):e3620. PubMed ID: 37973153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
    Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
    Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Prognostic Indicator Based on Autophagy-Related lncRNA Analysis in Colon Adenocarcinoma.
    Zhou W; Zhang S; Li HB; Cai Z; Tang S; Chen LX; Lang JY; Chen Z; Chen XL
    Biomed Res Int; 2020; 2020():9807918. PubMed ID: 32964050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a novel ferroptosis-related lncRNA pair prognostic model in colon adenocarcinoma.
    Li H; Liu L; Huang T; Jin M; Zheng Z; Zhang H; Ye M; Liu K
    Aging (Albany NY); 2021 Oct; 13(19):23072-23095. PubMed ID: 34610581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
    He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
    Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
    Tan Y; Lu L; Liang X; Chen Y
    World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Four-Gene Metabolic Signature to Evaluate the Prognosis of Colon Adenocarcinoma Patients.
    Zheng Y; Wu R; Wang X; Yin C
    Front Public Health; 2022; 10():860381. PubMed ID: 35462848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.